221029-72-7 Usage
Uses
Used in Pharmaceutical Industry:
(E)-3-Methoxy-4-((2-(pyridin-3-yl)-5,6-dihydropyridin-3(4H)-ylidene)Methyl)phenol is used as a potential candidate for the development of new drugs, leveraging its unique structure and potential biological activities to address various medical needs.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (E)-3-Methoxy-4-((2-(pyridin-3-yl)-5,6-dihydropyridin-3(4H)-ylidene)Methyl)phenol serves as a valuable compound for further research and exploration. Its complex structure and potential interactions with biological targets make it an interesting subject for the discovery of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 221029-72-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,1,0,2 and 9 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 221029-72:
(8*2)+(7*2)+(6*1)+(5*0)+(4*2)+(3*9)+(2*7)+(1*2)=87
87 % 10 = 7
So 221029-72-7 is a valid CAS Registry Number.
221029-72-7Relevant academic research and scientific papers
NOVEL ANABASEINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
-
Page/Page column 82-83, (2010/11/28)
Disclosed are novel anabaseine derivatives that act as agonists of the α7 nAChR. Also disclosed are pharmaceutical compositions, methods- of treating inflammatory conditions, methods of treating CNS disorders, methods for inhibiting cytokine release from
CONTROLLING ANGIOGENESIS WITH ANABASEINE ANALOGS
-
Page/Page column 58, (2008/06/13)
Compounds controlling angiogenesis and vasculogenesis. In particular, induction of angiogenesis to promote growth of new vasculature by the use of anabaseine agonists and to the reduction of pathological angiogenesis by the use of anabaseine antagonists.
